An antiserum to idazoxan recognizes an immunoreactive substance in human serum and cerebral spinal fluid which is not agmatine

Neurochemistry International

Volumn 30, Issue 1, 1997, Pages 85-94

  Wang, H ^a   Regunathan, S ^a   McGowan, D ^a   Bramwell, S ^a   Reis, D J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGMATINE; AMILORIDE; BRIMONIDINE; CIRAZOLINE; CLONIDINE DISPLACING SUBSTANCE; GUANABENZ; IDAZOXAN; NAPHAZOLINE; POLYCLONAL ANTIBODY;

ANIMAL TISSUE; ARTICLE; CATTLE; CEREBROSPINAL FLUID; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

AGMATINE; ANIMALS; ANTIBODY SPECIFICITY; ANTIGENS; CATTLE; CLONIDINE; HUMANS; IDAZOXAN; IMMUNE SERA; RADIOIMMUNOASSAY; RATS; RECEPTORS, DRUG; SERUM ALBUMIN, BOVINE;

EID: 0031033157     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(96)00041-1     Document Type: Article

References (35)

1. Atlas, D. (1994) Identifying clonidine-displacing substance [letter]. Science 266, 462.
2. 2-adrenergic receptor activity. Biochem. Pharmacol. 41, 1541-1549.
3. Atlas, D. and Burstein, Y. (1984) Isolation and partial purification of a clonidine-displacing endogenous brain substance. Eur. J. Biochem. 144, 287-293.
4. Bennai, F., Greney, H., Bricca, G., Belcourt, A., Bousquet, P. and Dontenwill, M. (1993) Polyclonal anti-idazoxan antibodies: characterization and purification. Eur. J. Pharmacol. 246, 45-51.
5. Bousquet, P., Feldman, J. and Atlas, D. (1986) An endogenous, non-catecholamine clonidine antagonist increases mean arterial blood pressure. Eur. J. Pharmacol. 124, 167-170.
6. Bricca, G., Dontenwill, M., Molines, A., Feldman, J., Belcourt, A. and Bousquet, P. (1989) The imidazoline preferring receptor: binding studies in bovine, rat and human brainstem. Eur. J. Pharmacol. 162, 1-9.
7. Coupry, I., Atlas, D., Podevin, R. A., Uzielli, I. and Parini, A. (1989) Imidazoline guanidinium receptive sites in renal proximal tubule: asymmetric distribution, regulation by cations and interaction with an endogenous clonidine displacing substance. J. Pharmacol. Exp. Ther. 252, 293-299.
8. Diamant, S. and Atlas, D. (1986) An endogenous brain substance, CDS (clonidine-displacing-substance), inhibits the twitch response of rat vas deferens. Biochem. Biophys. Res. Commun. 134, 184-190.
9. Diamant, S., Eldor, A. and Atlas, D. (1987) A low molecular weight brain substance interacts, similarly to clonidine, with α2-adrenoceptors of human platelets. Eur. J. Pharmacol. 144, 247-255.
10. Dontenwill, M., Bricca, G., Molines, A., Bousquet, P. and Belcourt, A. (1988) Production and characterization of anti-clonidine antibodies not cross-reacting with catecholamines. Eur. J. Pharmacol. 149, 249-255.
11. Dontenwill, M., Molines, A., Bricca, G., Stutzman, J., Kempf, J., Belcourt, A. and Bousquet, P. (1992) Production and characterization of an iminoimidazolidine specific monoclonal antibody using para-aminoclonidine as antigen. Life Sci. 50, 1859-1868.
12. Dontenwill, M., Molines, A., Verdun, A., Bricca, G., Laurent S. and Bousquet P. (1993) A circulating substance cross-reacting with antiimidazoline antibodies: detection in serum in relation to essential hypertension. J. Clin. Invest. 92, 1068-1072.
13. 2-adrenoceptors in the ventrolateral medulla. Eur. J. Pharmacol. 134, 1-14.
14. Ernsberger, P., Meeley, M. P. and Reis, D. J. (1988) An endogenous substance with clonidine-like properties: selective binding to imidazole sites in the ventrolateral medulla. Brain Res. 441, 309-318.
15. Felsen, D., Ernsberger, P., Meeley, M. P. and Reis, D. J. (1987) Clonidine displacing substance is biologically active on smooth muscle. Eur. J. Pharmacol. 142, 453-455.
16. Goldberg-Stern, H., Atlas, D., Schwartz, I., Achiron, A., Ziv, I., Djaldetti, R., Zoldan, Y. and Melamed, E. (1993) Detection and measurement of an endogenous clonidine-displacing substance in human cerebrospinal fluid. Brain Res. 601, 325-328.
17. Kreisberg, G. A., Diamant, S., Diamant, Y. Z. and Atlas, D. (1987) Raised levels of an endogenous nonadrenergic substance in the serum of pregnancy-induced hypertension patients. Isr. J. Med. Sci. 23, 1194-1197.
18. Li, G., Regunathan, S., Barrow, C. J., Eshraghi, J., Cooper, R. and Reis, D. J. (1994) Agmatine is an endogenous clonidine-displacing substance in brain. Science 263, 966-969.
19. Meeley, M. P., Ernsberger, P. R., Granata, A. R. and Reis, D. J. (1986) An endogenous clonidine-displacing substance from bovine brain: receptor binding and hypotensive actions in the ventrolateral medulla. Life Sci. 38, 1119-1126.
20. Meeley, M. P., Towle, A. C., Char, L. K., Ernsberger, P. and Reis, D. J. (1986) Polyclonal antiserum to a paraaminoclonidine conjugate recognizes an endogenous clonidine-like susbtance(s) in brain. Soc. Neurosci. Abstr. 12, 963.
21. Meeley, M. P., Hensley, M. L., Ernsberger, P., Felsen, D. and Reis, D. J. (1992) Evidence for a bioactive clonidine-displacing substance in peripheral tissues and serum. Biochem. Pharmacol. 44, 733-740.
22. Meeley, M. P., Towle, A. C., Ernsberger, P., Char, I. K., McCauley, P. M. and Reis, D. J. (1989) Clonidine-specific antisera recognize an endogenous clonidine-displacing substance in brain. Hypertension 13, 341-351.
23. Meeley M., P., Towle, A. C., Ernsberger, P. and Reis, D. J. (1988) A specific antiserum recognizes clonidine-displacing substance: implications for the structure of the brain's own clonidine. Neurosci. Lett. 84, 84-90.
24. Michel, M. C. and Ernsberger, P. L. (1992) Keeping an eye on the I site: imidazoline-preferring receptors. Trends Pharmacol. Sci. 13, 369-370.
25. Michel, M. C. and Insel, P. A. (1989) Are there multiple imidazoline binding sites?. Trends Pharmacol. Sci. 10, 342-344.
26. 2-adrenergic receptor. J. Biol. Chem. 264, 11874-11878.
27. 2-adrenergic receptors. J. Pharmacol. Exp. Ther. 272, 581-587.
28. Raasch, W., Regunathan, S., Li, G. and Reis, D. J. (1995) Agmatine, the bacterial amine, is widely distributed in mammalian tissues. Life. Sci. 56, 2319-2330.
29. Regunathan, S., Meeley, M. P. and Reis, D. J. (1991) Clonidine-displacing substance from bovine brain binds to imidazoline receptors and releases catecholamines in adrenal chromaffin cells. Mol. Pharmacol. 40, 884-888.
30. Regunathan, S., Meeley, M. P. and Reis, D. J. (1993) Expression of nonadrenergic imidazoline sites in chromaffin cells and mitochondrial membranes of bovine adrenal medulla. Biochem. Pharmacol. 45, 1667-1675.
31. Reis, D. J., Li, G. and Regunathan, S. (1995) Endogenous ligands of imidazoline receptors: classic and immunoreactive clonidine displacing substance (CDS) and agmatine. Ann. NY Acad. Sci. 763, 295-313.
32. Reis, D. J., Li, G., Regunathan, S., Barrow, C. J. and Cooper, R. (1994) Identifying clonidine-displacing substance (response). Science 266, 462-463.
33. Synetos, D., Manolopoulos, V. G., Atlas D. and Pipili-Synetos, E. (1991) Human plasma-derived material with clonidine displacing substance (CDS)-like properties contracts the isolated rat aorta. J. Auton. Pharmacol. 11, 343-351.
34. Tesson, F., Prip-Buus, C., Lemoine, A., Pegorier, J-P. and Parini, A. (1991) Subcellular distribution of imidazoline guanidinium-receptive sites in human and rabbit liver: major localization to the mitochondrial outer membrane. J. Biol. Chem. 260, 155-160.
35. Wang, H., Regunathan, S., Meeley, M. P. and Reis, D. J. (1992) Isolation and characterization of imidazoline receptor proteins from bovine adrenal chromaffin cells. Mol. Pharmacol. 42, 792-801.